Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H23N3O4 |
Molecular Weight | 309.3608 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCCNC(=O)C1=CC(=NC=C1)C(=O)NCCCOC
InChI
InChIKey=HLSXICGBWKECLM-UHFFFAOYSA-N
InChI=1S/C15H23N3O4/c1-21-9-3-6-17-14(19)12-5-8-16-13(11-12)15(20)18-7-4-10-22-2/h5,8,11H,3-4,6-7,9-10H2,1-2H3,(H,17,19)(H,18,20)
Molecular Formula | C15H23N3O4 |
Molecular Weight | 309.3608 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Aventis developed safironil as a competitive inhibitor of collagen protein synthesis for the treatment of liver disorders. This compound participated in phase I clinical trial for the treatment of cirrhosis in Germany. In addition, it was studied for hepatic fibrosis treatment. However, information about the further development of this compound is not available.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:04:47 GMT 2023
by
admin
on
Sat Dec 16 17:04:47 GMT 2023
|
Record UNII |
CK4M8AX1LN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID60158677
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
134377-69-8
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
C109927
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
CK4M8AX1LN
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
7018
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
SUB10413MIG
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105464
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
100000084372
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
65973
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY | |||
|
C74278
Created by
admin on Sat Dec 16 17:04:47 GMT 2023 , Edited by admin on Sat Dec 16 17:04:47 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |